- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Torrent Pharmaceuticals has announced a board meeting on May 20, 2025, approving the financial results for the quarter and half-year. Consolidated revenue rose 8% YoY to Rs. 2,959 Cr in Q4 FY25, with net profit up 11% to Rs. 498 Cr. Growth was led by the India business (+12%), driven by strong chronic therapies. The US business expanded 15%, while Brazil and Germany showed currency-adjusted growth. The Board proposed a final dividend of Rs. 6 per share, following an interim dividend of Rs. 26 per share. Aman Mehta has been appointed Managing Director for five years from August 1, 2025, subject to shareholder approval, reflecting his role in scaling the India business and strengthening operations.